STEPHEN WARRENBURG, Ph.D.; GARY E. SCHWARTZ, Ph.D.; RICHARD HENDERSON, Ph.D.; PAUL CRITS-CHRISTOPH, Ph.D.; PATRICIA NUZZO, B.S.
This content is PDF only. Please click on the PDF icon to access.
To the editor: In December 1985, McCarron and Morris (1) reported that calcium supplementation leads to a clinically significant lowering ( > 10 mm Hg) of blood pressure in a subset (44%) of hypertensive persons tested in a randomized, placebo, crossover trial. They proposed that impaired calcium metabolism is a critical factor in the pathogenesis of both human and experimental hypertension. In a previous issue of Annals (2), McCarron suggested that the elevated prevalence of hypertension in blacks may be calcium related, but there were too few black hypertensive persons in their recent sample to allow testing of this hypothesis.
WARRENBURG S, SCHWARTZ GE, HENDERSON R, et al. Calcium, Race, and Hypertension. Ann Intern Med. 1986;104:892–893. doi: https://doi.org/10.7326/0003-4819-104-6-892_3
Download citation file:
Published: Ann Intern Med. 1986;104(6):892-893.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use